Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 48th Annual San Antonio Breast Cancer Symposium

Listen Now

Topics Covered

• Updates from the 48th Annual SABCS on Diagnostic Testing, Biomarkers, Precision Medicine, Grade & Hormone Receptors
• What’s New in the Treatment of ER, PR & HER2 Positive Breast Cancer
• Updates from SABCS on Hormone & Targeted Therapy
• Chemotherapy Updates from SABCS
• Investigational New Drugs in Clinical Trials Reported at SABCS
• What’s New in Preventing & Managing Treatment Side Effects, including Discomfort, Neuropathy & Long-Term Effects of Treatment for Breast Cancer
• Key Questions to Ask Your Health Care Team
• Guidelines to Prepare for Telehealth/Telemedicine Appointments Including Technology, Prepared List of Questions & Discussion of OpenNotes
• Quality-of-Life Concerns
• Questions for Our Panel of Experts

Our Panel of Experts

Kamel Abou Hussein, MD

Assistant Professor of Medicine, Cooper Medical School of Rowan University, Adjunct Assistant Professor, Department of Breast Medical Oncology, MD Anderson Cancer Center, Co-Director of the Janet Knowles Breast Cancer Program, Director of Breast Cancer Clinical Trials, MD Anderson Cancer Center at Cooper

Danny Markabawi, MD

Assistant Professor of Medicine, Breast Medical Oncology, Cooper Medical School of Rowan University

Jennifer LaPietra, MSW

Patient Assistance Program Manager, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on February 25, 2026.